title: Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma.
authors.forename: Shoji
authors.initials: S
authors.lastname: Pellissery
authors.forename: Julia
authors.initials: J
authors.lastname: Richter
authors.forename: Andrea
authors.initials: A
authors.lastname: Haake
authors.forename: Manuel
authors.initials: M
authors.lastname: Montesinos-Rongen
authors.forename: Martina
authors.initials: M
authors.lastname: Deckert
authors.forename: Reiner
authors.initials: R
authors.lastname: Siebert
mesh_terms: D001706:Biopsy; D045744:Cell Line, Tumor; D016543:Central Nervous System Neoplasms / Q000235:genetics* / Q000473:pathology; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000235:genetics*; D000071221:Enhancer of Zeste Homolog 2 Protein; D005787:Gene Frequency; D006801:Humans; D008223:Lymphoma / Q000235:genetics*; D020125:Mutation, Missense / Q000502:physiology; D063151:Polycomb Repressive Complex 2; D014157:Transcription Factors / Q000235:genetics*; D014443:Tyrosine / Q000235:genetics
chemical_list: D004268:DNA-Binding Proteins; D014157:Transcription Factors; D014443:Tyrosine; C498409:EZH2 protein, human; D000071221:Enhancer of Zeste Homolog 2 Protein; D063151:Polycomb Repressive Complex 2